In addition, we constructed 3D patient tumor avatars derived from patients with PCa through 3D bioprinting, named 3D bioprinted PCa organoids (3DP-POs), to further confirm the sensitivity of SPOP-mutated PCa to olaparib (Figure 8, A and B). The gene discussed is SPOP; the disease is neoplasm.